Drug Shortage Report for EMEND IV

Last updated on 2021-08-31 History
Report ID 144168
Drug Identification Number 02363356
Brand name EMEND IV
Common or Proper name fosaprepitant for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) FOSAPREPITANT
Strength(s) 150MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 150MG 1DOSE LOW EDTA VIAL
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2021-08-27
Actual start date 2021-08-27
Estimated end date 2021-09-03
Actual end date 2021-08-30
Shortage status Resolved
Updated date 2021-08-31
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-08-31 French Compare
v7 2021-08-30 French Compare
v6 2021-08-30 English Compare
v5 2021-08-28 English Compare
v4 2021-08-27 English Compare
v3 2021-08-16 French Compare
v2 2021-08-16 English Compare
v1 2021-08-16 English Compare